Search Results

There are 21485 results for: content related to: Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma

  1. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  2. You have free access to this content
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  3. Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma

    Journal of Surgical Oncology

    Volume 106, Issue 2, 1 August 2012, Pages: 174–180, Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Akira Nakashima, Naru Kondo, Naoya Nakagawa and Taijiro Sueda

    Version of Record online : 13 FEB 2012, DOI: 10.1002/jso.23068

  4. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  5. Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 606–619, Soley Bayraktar and Caio M. Rocha-Lima

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20217

  6. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  7. You have free access to this content
    Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin

    BJU International

    Volume 103, Issue 3, February 2009, Pages: 384–390, Mototsugu Muramaki, Alan So, Norihiro Hayashi, Richard Sowery, Hideaki Miyake, Masato Fujisawa and Martin E. Gleave

    Version of Record online : 24 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08098.x

  8. You have free access to this content
    Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 1119–1129, James D. Murphy, Daniel T. Chang, Jon Abelson, Megan E. Daly, Heidi N. Yeung, Lorene M. Nelson and Albert C. Koong

    Version of Record online : 19 JUL 2011, DOI: 10.1002/cncr.26365

  9. You have free access to this content
    Chemotherapy for advanced non-small cell lung cancer in the elderly population

    Intervention Review

    The Cochrane Library

    Fábio N Santos, Tiago B de Castria, Marcelo RS Cruz and Rachel Riera

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010463.pub2

  10. You have free access to this content
    A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

    Cancer

    Volume 98, Issue 9, 1 November 2003, Pages: 1863–1869, Barbara J. Gitlitz, Carole Baker, Yvonne Chapman, Heather J. Allen, Linda D. Bosserman, Ravi Patel, James D. Sanchez, Richard M. Shapiro and Robert A. Figlin

    Version of Record online : 30 SEP 2003, DOI: 10.1002/cncr.11726

  11. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  12. You have full text access to this OnlineOpen article
    Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer

    Cancer Science

    Volume 106, Issue 4, April 2015, Pages: 397–406, Shuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, Tatsuo Matsuda, Tomonobu Fujita, Hajime Higuchi, Junichi Taguchi, Hiroya Takeuchi, Osamu Itano, Koichi Aiura, Yasuo Hamamoto, Hiromasa Takaishi, Masato Okamoto, Makoto Sunamura, Yutaka Kawakami and Yuko Kitagawa

    Version of Record online : 9 MAR 2015, DOI: 10.1111/cas.12621

  13. You have full text access to this OnlineOpen article
    Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 925–932, Andres Forero-Torres, Jeffrey R. Infante, David Waterhouse, Lucas Wong, Selwyn Vickers, Edward Arrowsmith, Aiwu Ruth He, Lowell Hart, David Trent, James Wade, Xiaoping Jin, Qiang Wang, TaShara Austin, Michael Rosen, Robert Beckman, Reinhard von Roemeling, Jonathan Greenberg and Mansoor Saleh

    Version of Record online : 25 OCT 2013, DOI: 10.1002/cam4.137

  14. You have full text access to this OnlineOpen article
    Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

    Cancer Medicine

    Volume 4, Issue 8, August 2015, Pages: 1224–1239, Neelam V. Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison M. Ivey and Thomas J George Jr

    Version of Record online : 13 MAR 2015, DOI: 10.1002/cam4.444

  15. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma

    HPB

    Volume 17, Issue 7, July 2015, Pages: 587–593, May Cho, Andrea Wang-Gillam, Robert Myerson, Feng Gao, Steven Strasberg, Joel Picus, Steven Sorscher, Chloe Fournier, Gayathri Nagaraj, Parag Parikh, Rama Suresh, David Linehan and Benjamin R. Tan

    Version of Record online : 20 MAR 2015, DOI: 10.1111/hpb.12413

  16. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

    Radiation Oncology Investigations

    Volume 5, Issue 2, 1997, Pages: 62–71, Marion A. Joschko, Lorraine K. Webster, Janice Groves, Kally Yuen, Manuela Palatsides, David L. Ball and Michael J. Millward

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H

  17. Adjuvant therapy for pancreas adenocarcinoma

    Journal of Surgical Oncology

    Volume 107, Issue 1, 1 January 2013, Pages: 78–85, Eileen M. O'Reilly

    Version of Record online : 6 AUG 2012, DOI: 10.1002/jso.23230

  18. Epidermal growth factor receptor blockers for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Krishnayan Haldar, Kezia Gaitskell, Andrew Bryant, Shibani Nicum, Sean Kehoe and Jo Morrison

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD007927.pub3

  19. Biweekly gemcitabine plus S-1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 22, Issue 9, September 2015, Pages: 692–698, Keita Wada, Keiji Sano, Hodaka Amano, Fumihiko Miura, Naoyuki Toyota, Hiromichi Ito, Makoto Shibuya, Yutaka Ikeda, Masahiko Kainuma and Tadahiro Takada

    Version of Record online : 1 JUL 2015, DOI: 10.1002/jhbp.274

  20. You have free access to this content
    Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 998–1007, Gabriela B Iwanski, Dhong H Lee, Shlomit En-Gal, Ngan B Doan, Brandon Castor, Marco Vogt, Melvin Toh, Carsten Bokemeyer, Jonathan W Said, Nils H Thoennissen and H Phillip Koeffler

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00741.x